These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20120349)

  • 21. P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.
    Graus F; Lang B; Pozo-Rosich P; Saiz A; Casamitjana R; Vincent A
    Neurology; 2002 Sep; 59(5):764-6. PubMed ID: 12221175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Lambert-Faton myasthenic syndrome and subacute cerebellar degeneration with a favorable clinical course after resection of small-cell lung cancer].
    Shimamura M; Yamaguchi S; Kuroiwa Y
    Rinsho Shinkeigaku; 2000 Oct; 40(10):1028-32. PubMed ID: 11296368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lambert-Eaton Myasthenic Syndrome.
    Kesner VG; Oh SJ; Dimachkie MM; Barohn RJ
    Neurol Clin; 2018 May; 36(2):379-394. PubMed ID: 29655456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Report of a case of small cell lung cancer associated with Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration--with a review of the Japanese literature].
    Ohkubo K; Ohishi K; Motomura M; Sakai K; Tsujihata M; Nagataki S
    No To Shinkei; 1994 Mar; 46(3):285-9. PubMed ID: 8192944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An autoimmune channelopathy associated with cancer: Lambert-Eaton myasthenic syndrome.
    Takamori M
    Intern Med; 1999 Feb; 38(2):86-96. PubMed ID: 10225662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct evolution of calcium channel antibody types in Lambert-Eaton myasthenic syndrome.
    Martin-Moutot N; De Haro L; Seagar M
    J Neuroimmunol; 2008 Jun; 197(1):47-53. PubMed ID: 18474401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.
    Voltz R; Carpentier AF; Rosenfeld MR; Posner JB; Dalmau J
    Muscle Nerve; 1999 Jan; 22(1):119-22. PubMed ID: 9883867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lambert-Eaton myasthenic syndrome: diagnosis and treatment].
    Motomura M; Iwanaga H
    Clin Calcium; 2001 Nov; 11(11):1468-74. PubMed ID: 15775666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases].
    Motomura M
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1237-9. PubMed ID: 10791087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies.
    Pavolucci L; Giannini G; Giannoccaro MP; Foschini MP; Lang B; Avoni P; Tinuper P; Vincent A; Liguori R
    Muscle Nerve; 2017 Nov; 56(5):998-1000. PubMed ID: 28006860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lambert-Eaton myasthenic syndrome in a patient with small cell lung cancer].
    Kuge T; Sakamoto M; Nomiyama H; Koyama N; Mikasa K; Narita N
    Nihon Naika Gakkai Zasshi; 2000 Feb; 89(2):350-2. PubMed ID: 10756651
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of small cell carcinoma of the lung associated with paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome].
    Seki N; Mitsui J; Hoshino M; Akishiro M; Ugawa Y; Goto J; Tsuji S
    No To Shinkei; 2006 Jan; 58(1):68-73. PubMed ID: 16482925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to synthetic peptides of the alpha1A subunit of the voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome.
    Takamori M; Iwasa K; Komai K
    Neurology; 1997 May; 48(5):1261-5. PubMed ID: 9153453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.